The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Regional distribution of serotonin transporter protein in postmortem human brain
Abstract
Introduction The primary approach in assessing the status of brain serotonin neurons in human conditions such as major depression and exposure to the illicit drug ecstasy has been the use of neuroimaging procedures involving radiotracers that bind to the serotonin transporter (SERT). However, there has been no consistency in the selection of a "SERT-free" reference region for the estimation of free and nonspecific binding, as occipital cortex, cerebellum and white matter have all been employed.Objective and methods To identify areas of human brain that might have very low SERT levels, we measured, by a semiquantitative Western blotting procedure, SERT protein immunoreactivity throughout the postmortem brain of seven normal adult subjects.Results Serotonin transporter could be quantitated in all examined brain areas. However, the SERT concentration in cerebellar cortex and white matter were only at trace values, being approximately 20% of average cerebral cortex and 5% of average striatum values.Conclusion Although none of the examined brain areas are completely free of SERT, human cerebellar cortex has low SERT binding as compared to other examined brain regions, with the exception of white matter. Since the cerebellar cortical SERT binding is not zero, this region will not be a suitable reference region for SERT radioligands with very low free and nonspecific binding. For SERT radioligands with reasonably high free and nonspecific binding, the cerebellar cortex should be a useful reference region, provided other necessary radioligand assumptions are met.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In normal post-mortem human cerebellum, there is a relatively low concentration of 5-HT transporters (SERT) compared to other brain regions except in the white matter and can be used as a reference region in binding studies looking at other brain regions with higher binding densities [184].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [184]
Citations
Cites
Ichise, M., Liow, J., Lu, J., Takano, A., Modell, K. J., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 651
Tritiated Imipramine Binding Sites Are Decreased in the Frontal Cortex of Suicides
Stanley, M., Virgilio, J., & Gershon, S. (1982) · Science · doi:10.1126/science.7079769 · Cited by 473
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M. A., Abi‐Dargham, A., Wallace, E. A., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V. S., Hussey, D. F., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 339
Self-citationHoule, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000365 · Cited by 276
Self-citationQian, Y., Melikian, H. E., Rye, D., Levey, A. I., & Blakely, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01261.1995 · Cited by 256
Wilson, A. A., Ginovart, N., Schmidt, M. E., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationBernheimer, H., Birkmayer, W., & Hornykiewicz, O. (1961) · Journal of Molecular Medicine · doi:10.1007/bf01487648 · Cited by 240
Isolation of a cDNA encoding the human brain serotonin transporter
Lesch, K., Wolozin, B. L., Estler, H.-C., Murphy, D. L., & Riederer, P. F. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244919 · Cited by 226
Cortés, R., Soriano, E., Pazos, Á., Probst, A., & Palacios, J. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90282-5 · Cited by 217
Cited by
Sorted by citations
Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Kish, S. J., Tong, J., Hornykiewicz, O., Rajput, A. H., Chang, L.-J., Guttman, M., & Furukawa, Y. (2007) · Brain · doi:10.1093/brain/awm239 · Cited by 376
Self-citationSerotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants
Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Rehncrona, S., Björklund, A., Lindvall, O., & Piccini, P. P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000976 · Cited by 322
Maillet, A., Krack, P., Lhommée, E., Météreau, É., Klinger, H., Favre, É., Bars, D. L., Schmitt, E., Bichon, A., Pélissier, P., et al. (2016) · Brain · doi:10.1093/brain/aww162 · Cited by 300
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment
Meyer, J. H. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0709 · Cited by 276
Self-citation
Metadata
- Authors
- Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Kish, Stephen J.
- ORCID
- Venue
- Nuclear Medicine and Biology
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 32
- Issue
- 2
- Pages
- 123-128
- ISSN
- 0969-8051 (ISSN-L)
- OpenAlex
- W55536439
- Cited by
- 179
- References
- 33
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 13 · 2013: 12 · 2012: 11
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nuclear Medicine and Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute on Drug Abuse (DA 7182, R01DA007182)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- serotonin transporter, postmortem brain, cerebellar cortex, white matter, reference region, non-specific binding, major depressive disorder, ecstasy, serotonergic neurons
- MeSH terms
- Brain, Cadaver, Cerebellum, Humans, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Neurons, Reference Values, Tissue Distribution, Blotting, Western, Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review